AstraZeneca PLC
1558.00
10-March-25 10:15:06
15 minutes delayed
Stocks
-14.00
-0.89%
Today's range
1529.50 - 1560.50
ISIN
N/A
Source
NASD.OMX SE
-
AZN : Imfinzi Improves Event-Free Survival In Early-Stage Gastric & GEJ Cancers In Phase III Trial
07 Mar 2025 01:51:13 By NASDAQ US Markets
-
AZN: TEZSPIRE Reduces Nasal Polyp Severity And Surgery Need In CRSwNP Patients In Phase III Trial
01 Mar 2025 20:14:04 By NASDAQ US Markets
-
AstraZeneca's Camizestrant Shows Positive Interim Results In SERENA-6 Phase 3 Trial
26 Feb 2025 01:43:24 By NASDAQ US Markets
-
FibroGen Announces Sale of China Subsidiary to AstraZeneca for Approximately $160 Million
20 Feb 2025 06:51:49 By NASDAQ Stocks
-
Ex-Dividend Reminder: Vestis Corp, ONE Gas and AstraZeneca
19 Feb 2025 09:26:27 By NASDAQ US Markets
-
Ex-Dividend Reminder: Vestis Corp, ONE Gas and AstraZeneca
19 Feb 2025 09:06:54 By NASDAQ Stocks
-
2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025
15 Feb 2025 08:07:29 By NASDAQ US Markets
-
AZN April 4th Options Begin Trading
13 Feb 2025 11:18:24 By NASDAQ US Markets
-
Why AstraZeneca Topped the Market on Thursday
06 Feb 2025 16:24:24 By NASDAQ US Markets
-
AstraZeneca Plc (AZN) Q4 2024 Earnings Call Transcript
06 Feb 2025 13:13:48 By NASDAQ US Markets
-
06 Feb 2025 09:38:48 By NASDAQ US Markets
-
AstraZeneca: CHMP Recommends Approval Of Imfinzi In The EU
03 Feb 2025 01:58:39 By NASDAQ US Markets
-
Interesting AZN Put And Call Options For March 14th
30 Jan 2025 10:09:34 By NASDAQ US Markets
-
FDA Approves AstraZeneca And Daiichi Sankyo's ENHERTU For HER2-Low/Ultralow Breast Cancer
27 Jan 2025 19:00:56 By NASDAQ US Markets
-
InnovationRx: The Impact Of Trump’s Withdrawal From The WHO And His Other Healthcare Orders
22 Jan 2025 12:41:38 By Forbes - World
-
FDA Okays AstraZeneca And Daiichi's Datroway For Metastatic HR-Positive, HER2-Negative Breast Cancer
18 Jan 2025 00:34:04 By NASDAQ US Markets
-
Better Buy: Novo Nordisk vs. AstraZeneca
04 Jan 2025 05:11:10 By NASDAQ US Markets
-
Syncona: Achilles Announces Sale Of Technology Assets To AstraZeneca - Quick Facts
27 Dec 2024 01:32:04 By NASDAQ US Markets
-
AstraZeneca And Daiichi Sankyo Withdraw EU Marketing Application For Datopotamab Deruxtecan
24 Dec 2024 01:40:25 By NASDAQ US Markets
-
22 Dec 2024 05:16:51 By NASDAQ US Markets
- <<
- <
- 1
- >